Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fostair 100micrograms/dose / 6micrograms/dose inhaler
0302000C0BQAABX
|
Fostair (old) | Beclometasone dipropionate | Respiratory System | 949,350 |
|
Clenil Modulite 100micrograms/dose inhaler
0302000C0BPABBF
|
Clenil Modulite | Beclometasone dipropionate | Respiratory System | 701,400 |
|
Fostair NEXThaler 100microg/dose / 6microg/dose dry pdr inh
0302000C0BRAABY
|
Fostair NEXThaler (old) | Beclometasone dipropionate | Respiratory System | 344,981 |
|
Beclometasone 50micrograms/dose nasal spray
1202010C0AAAAAA
|
Beclometasone dipropionate (Nasal) | Beclometasone dipropionate | Ear, Nose and Oropharynx | 331,151 |
|
Fostair 200micrograms/dose / 6micrograms/dose inhaler
0302000C0BQABBZ
|
Fostair (old) | Beclometasone dipropionate | Respiratory System | 327,913 |
|
Luforbec 100micrograms/dose / 6micrograms/dose inhaler
0302000C0BUAABX
|
Luforbec (old) | Beclometasone dipropionate | Respiratory System | 197,391 |
|
Clenil Modulite 50micrograms/dose inhaler
0302000C0BPAABE
|
Clenil Modulite | Beclometasone dipropionate | Respiratory System | 191,886 |
|
Clenil Modulite 200micrograms/dose inhaler
0302000C0BPACBV
|
Clenil Modulite | Beclometasone dipropionate | Respiratory System | 149,438 |
|
Beconase Aqueous 50micrograms/dose nasal spray
1202010C0BBABAA
|
Beconase | Beclometasone dipropionate | Ear, Nose and Oropharynx | 130,454 |
|
Fostair NEXThaler 200microg/dose / 6microg/dose dry pdr inh
0302000C0BRABCA
|
Fostair NEXThaler (old) | Beclometasone dipropionate | Respiratory System | 108,654 |
|
Qvar 100 inhaler
0302000C0BJABBF
|
Qvar | Beclometasone dipropionate | Respiratory System | 104,430 |
|
Soprobec 100micrograms/dose inhaler
0302000C0BTACBF
|
Soprobec | Beclometasone dipropionate | Respiratory System | 98,991 |
|
Qvar 50 inhaler
0302000C0BJAABE
|
Qvar | Beclometasone dipropionate | Respiratory System | 57,116 |
|
Luforbec 200micrograms/dose / 6micrograms/dose inhaler
0302000C0BUABBZ
|
Luforbec (old) | Beclometasone dipropionate | Respiratory System | 54,860 |
|
Beclometasone 100microg/Formoterol 6microg/dose inh CFC free
0302000C0AABXBX
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 39,522 |
|
Easyhaler Beclometasone 200micrograms/dose dry pdr inhaler
0302000C0BNAABU
|
Easyhaler (Beclometasone) | Beclometasone dipropionate | Respiratory System | 37,989 |
|
Beclometasone 100micrograms/dose inhaler CFC free
0302000C0AABFBF
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 31,794 |
|
Qvar 100micrograms/dose Easi-Breathe inhaler
0302000C0BJAFBH
|
Qvar | Beclometasone dipropionate | Respiratory System | 26,573 |
|
Kelhale 100micrograms/dose inhaler
0302000C0BSABBF
|
Kelhale | Beclometasone dipropionate | Respiratory System | 24,075 |
|
Soprobec 50micrograms/dose inhaler
0302000C0BTAABE
|
Soprobec | Beclometasone dipropionate | Respiratory System | 21,347 |
|
Soprobec 200micrograms/dose inhaler
0302000C0BTABBV
|
Soprobec | Beclometasone dipropionate | Respiratory System | 19,712 |
|
Clenil Modulite 250micrograms/dose inhaler
0302000C0BPADBW
|
Clenil Modulite | Beclometasone dipropionate | Respiratory System | 18,312 |
|
Qvar 100 Autohaler
0302000C0BJADBH
|
Qvar | Beclometasone dipropionate | Respiratory System | 17,035 |
|
Qvar 50micrograms/dose Easi-Breathe inhaler
0302000C0BJAEBG
|
Qvar | Beclometasone dipropionate | Respiratory System | 15,471 |
|
Beclometasone 50micrograms/dose inhaler CFC free
0302000C0AABEBE
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 12,023 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.